Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus

What Was Tested

The paper reports a study of ACTH (Corticotropin) and CRH (Corticotropin-Releasing Hormone), published as a randomized controlled trial.

The objective of the present study was to examine the effect of changes in plasma osmolality (pOsm) on the responses of the pituitary-adrenal axis to CRH and atrial natriuretic peptide (ANP) release in patients with central diabetes insipidus (DI).

Why It Was Studied

The DI group presented lower plasma ANP levels than controls during osmotic stimulus and isotonic volume loading.

The lower ANP secretion in DI patients corroborates the importance of neurohypophyseal hormones in ANP regulation.

Who Took Part

The age groups tagged for this paper are adults and middle-aged adults, both men and women.

How the Study Was Run

In design terms this was a randomized study.

Because people in this ACTH (Corticotropin) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

What Was Measured

The DI group presented lower plasma ANP levels than controls during osmotic stimulus and isotonic volume loading.

PubMed files the paper under topics including Adrenocorticotropic Hormone, Arginine Vasopressin, Atrial Natriuretic Factor, Corticotropin-Releasing Hormone, Diabetes Insipidus, Hydrocortisone and Isotonic Solutions.

What This Means in Plain Language

The paper is a randomized study of ACTH (Corticotropin) and CRH (Corticotropin-Releasing Hormone).

The publication is from 1997 (The Journal of clinical endocrinology and metabolism), a journal based in United States.

More context: the ACTH (Corticotropin) compound page and the CRH (Corticotropin-Releasing Hormone) compound page, all human trials.